Mary M. Gallenberg

455 total citations
12 papers, 355 citations indexed

About

Mary M. Gallenberg is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Mary M. Gallenberg has authored 12 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Reproductive Medicine, 5 papers in Obstetrics and Gynecology and 3 papers in Epidemiology. Recurrent topics in Mary M. Gallenberg's work include Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cervical Cancer and HPV Research (3 papers). Mary M. Gallenberg is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cervical Cancer and HPV Research (3 papers). Mary M. Gallenberg collaborates with scholars based in United States. Mary M. Gallenberg's co-authors include Lynn C. Hartmann, Giovanni Aletti, William A. Cliby, Aminah Jatoi, Charles L. Loprinzi, Teri Pipe, Mashele Huschka, Prema P. Peethambaram, Ann Marie Dose and Mary E. Johnson and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Annals of Oncology and Mayo Clinic Proceedings.

In The Last Decade

Mary M. Gallenberg

11 papers receiving 342 citations

Peers

Mary M. Gallenberg
ME Sherman United States
Shannon MacLaughlan United States
Richard Gunu United Kingdom
Kristen Bunch United States
Radhika Gogoi United States
Gail L. Brown United States
ME Sherman United States
Mary M. Gallenberg
Citations per year, relative to Mary M. Gallenberg Mary M. Gallenberg (= 1×) peers ME Sherman

Countries citing papers authored by Mary M. Gallenberg

Since Specialization
Citations

This map shows the geographic impact of Mary M. Gallenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary M. Gallenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary M. Gallenberg more than expected).

Fields of papers citing papers by Mary M. Gallenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary M. Gallenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary M. Gallenberg. The network helps show where Mary M. Gallenberg may publish in the future.

Co-authorship network of co-authors of Mary M. Gallenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mary M. Gallenberg. A scholar is included among the top collaborators of Mary M. Gallenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary M. Gallenberg. Mary M. Gallenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Long, Margaret E., et al.. (2012). Comparison of Dysplastic and Benign Endocervical Polyps. Journal of Lower Genital Tract Disease. 17(2). 142–146. 9 indexed citations
2.
Casey, Petra M., Mary M. Gallenberg, Brigitte A. Barrette, et al.. (2012). Outcomes in women age 40 years and older with cytologically benign endometrial cells. American Journal of Obstetrics and Gynecology. 207(5). 379.e1–379.e6.
3.
Aletti, Giovanni, et al.. (2010). From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer. Annals of Oncology. 21(9). 1772–1778. 3 indexed citations
4.
Johnson, Mary E., Ann Marie Dose, Teri Pipe, et al.. (2009). Centering Prayer for Women Receiving Chemotherapy for Recurrent Ovarian Cancer: A Pilot Study. Oncology nursing forum. 36(4). 421–428. 28 indexed citations
5.
Aletti, Giovanni, Mary M. Gallenberg, William A. Cliby, Aminah Jatoi, & Lynn C. Hartmann. (2007). Current Management Strategies for Ovarian Cancer. Mayo Clinic Proceedings. 82(6). 751–770. 141 indexed citations
6.
Aletti, Giovanni, Mary M. Gallenberg, William A. Cliby, Aminah Jatoi, & Lynn C. Hartmann. (2007). Current Management Strategies for Ovarian Cancer. Mayo Clinic Proceedings. 82(6). 751–770. 119 indexed citations
7.
Edmonson, John H., Vera J. Suman, Robert J. Dalton, et al.. (2001). Comparison of Conventional Dose and Double Dose Carboplatin in Patients Receiving Cyclophosphamide Plus Carboplatin for Advanced Ovarian Carcinoma: A North Central Cancer Treatment Group Study. Cancer Investigation. 19(6). 597–602. 7 indexed citations
8.
Gostout, Bobbie S., Lynn C. Hartmann, Vera J. Suman, et al.. (2001). A randomized trial of interferon‐alpha in cervical dysplasia. International Journal of Gynecology & Obstetrics. 74(2). 207–210. 3 indexed citations
9.
Gallenberg, Mary M. & Charles L. Loprinzi. (1989). Breast cancer and pregnancy.. PubMed. 16(5). 369–76. 39 indexed citations
10.
Coulam, Carolyn B., Mary M. Gallenberg, Maurice J. Webb, & Thomas A. Gaffey. (1982). The absence of H-Y antigen in XY gonads grossly resembling ovaries. American Journal of Obstetrics and Gynecology. 142(7). 925–927. 4 indexed citations
11.
Decker, David G., Thomas R. Fleming, George D. Malkasian, et al.. (1980). A treatment program for stage III and IV ovarian cancer — Cyclophosphamide versus cyclophosphamide and Cis-platinum. Gynecologic Oncology. 10(3). 368–369. 1 indexed citations
12.
Melton, L. Joseph, Mary M. Gallenberg, & Kenneth L. Noller. (1979). Effect of Elective Induction on Birth Weight. Mayo Clinic Proceedings. 54(10). 646–650. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026